BioSpace News Archive

Drug Development

Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) today announced that, as per protocol design, it is voluntarily pausing new patient enrollment in the company’s Phase 1/2 trial of seclidemstat as a treatment for Ewing sarcoma and FET-rearranged sarcomas.

October 18, 2022
·
7 min read
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares

VectivBio Holding AG announced the closing of its previously announced underwritten offering of 16,700,000 ordinary shares at an offering price of $7.50 per share.

October 18, 2022
·
4 min read
Pharm Country

Theranica Achieves Positive Results in Placebo-Controlled Pivotal Trial of Nerivio® for Preventive Treatment of Migraine

Theranica Bio-electronics today announced positive top-line results in its double-blind, randomized, placebo-controlled, multi-center, pivotal clinical trial in the USA (NCT04828707).

October 18, 2022
·
4 min read
Genetown

NeuroSense Therapeutics Provides CEO’s Q3 Update and Nasdaq Opening Bell Ceremony Remarks Video

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today provided a Q3 update and released the video of Founder and CEO Alon Ben-Noon’s remarks at the Nasdaq Opening Bell Ceremony on October 13, 2022.

October 18, 2022
·
5 min read
Drug Development

Iterion Therapeutics Announces Results from Preclinical Study of Tegavivint in Beta-Catenin Mutant Hepatocellular Carcinoma to be Presented at the 34th EORTC-NCI-AACR Symposium 2022

Iterion Therapeutics, Inc. announced that results from a preclinical murine study of tegavivint in beta-catenin activated hepatocellular carcinoma (HCC) will be featured in a poster presentation and discussion session at the 34th European Organisation for Research and Treatment of Cancer.

October 18, 2022
·
5 min read
Business

Science & Medicine Group Announces Top Life Science Editors to Lead LabPulse and The Science Advisory Board

Science and Medicine Group Inc. today announced the appointments of Leo O’Connor as Editor in Chief of LabPulse, and Greg Slabodkin as Editor in Chief of The Science Advisory Board.

October 18, 2022
·
4 min read
Deals

Verseon Acquires Edammo

Verseon International Corporation, the company leading a technology-driven transformation of the pharmaceutical industry, announces that it has acquired Edammo, Inc.

October 18, 2022
·
2 min read
Biotech Beach

VIRINX Announces the Successful Contactless Suppression of Wound-Infecting Bacteria by its Viper22 System

Virinx LLC (“VIRINX” or “the Company”), a developer of highly integrated IoT devices, announced the successful preliminary test results of its Viper22 system, which is a miniature noncontact wound and fungus infection treatment system.

October 18, 2022
·
1 min read
Business

The American Board of Oral and Maxillofacial Surgery Names New Leaders

The American Board of Oral and Maxillofacial Surgery named new leaders during their September 2022 Annual Meeting in New Orleans.

October 18, 2022
·
3 min read
FDA

Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea

Zhiyi Biotech announced that FDA has approved the Company’s Investigational New Drug (IND) application to develop SK10 (Inactivated Bacteroides fragilis ) for the treatment of Chemotherapy-induced Diarrhea (CID).

October 18, 2022
·
2 min read